ADAR1 Capital Management »

Revolution Medicines shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Revolution Medicines (RVMD) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Revolution Medicines

Tip: Access up to 7 years of quarterly data

All positions including Revolution Medicines held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revolution Medicines by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $12k 400 28.68

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Roivant Sciences SHS (ROIV)
Cytokinetics Com New (CYTK)
Arbutus Biopharma (ABUS)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Cerevel Therapeutics Hldng I (CERE)
Mirati Therapeutics
Merck & Co (MRK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Immunovant (IMVT)
Viking Therapeutics (VKTX)
Protagonist Therapeutics (PTGX)

View all positions for ADAR1 Capital Management

Top funds holding Revolution Medicines

Wellington Management Company
Vanguard Group
Nextech Invest
BVF
Casdin Capital
Alphabet
Baker Bros. Advisors
Bellevue Group
T. Rowe Price Associates
Jpmorgan Chase & Co
Boxer Capital
Arch Venture Corp
Deerfield Management Company
Holocene Advisors
Henderson Group

View all funds holding Revolution Medicines